Transforming the Medication Regimen Review Process Using Telemedicine to Prevent Adverse Events

© 2020 The American Geriatrics Society..

BACKGROUND/OBJECTIVES: Federally-mandated consultant pharmacist-conducted retrospective medication regimen reviews (MRRs) are designed to improve medication safety in nursing homes (NH). However, MRRs are potentially ineffective. A new model of care that improves access to and efficiency of consultant pharmacists is needed. The objective of this study was to determine the impact of pharmacist-led telemedicine services on reducing high-risk medication adverse drug events (ADEs) for NH residents using medication reconciliation and prospective MRR on admission plus ongoing clinical decision support alerts throughout the residents' stay.

DESIGN: Quality improvement study using a stepped-wedge design comparing the novel service to usual care in a one-year evaluation from November 2016 to October 2017.

SETTING: Four NHs (two urban, two suburban) in Southwestern Pennsylvania.

PARTICIPANTS: All residents in the four NHs were screened. There were 2,127 residents admitted having 652 alerts in the active period.

INTERVENTION: Upon admission, pharmacists conducted medication reconciliation and prospective MRR for residents and also used telemedicine for communication with cognitively-intact residents. Post-admission, pharmacists received clinical decision support alerts to conduct targeted concurrent MRRs and telemedicine.

MEASUREMENT: Main outcome was incidence of high-risk medication, alert-specific ADEs. Secondary outcomes included all-cause hospitalization, 30-day readmission rates, and consultant pharmacists' recommendations.

RESULTS: Consultant pharmacists provided 769 recommendations. The intervention group had a 92% lower incidence of alert-specific ADEs than usual care (9 vs 31; 0.14 vs 0.61/1,000-resident-days; adjusted incident rate ratio (AIRR) = 0.08 (95% confidence interval (CI) = 0.01-0.40]; P = .002). All-cause hospitalization was similar between groups (149 vs 138; 2.33 vs 2.70/1,000-resident-days; AIRR = 1.06 (95% CI = 0.72-1.58); P = .75), as were 30-day readmissions (110 vs 102; 1.72 vs 2.00/1,000-resident-days; AIRR = 1.21 (95% CI = 0.76-1.93); P = .42).

CONCLUSIONS: This is the first evaluation of the impact of pharmacist-led patient-centered telemedicine services to manage high-risk medications during transitional care and throughout the resident's NH stay, supporting a new model of patient care.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:69

Enthalten in:

Journal of the American Geriatrics Society - 69(2021), 2 vom: 01. Feb., Seite 530-538

Sprache:

Englisch

Beteiligte Personen:

Kane-Gill, Sandra L [VerfasserIn]
Wong, Adrian [VerfasserIn]
Culley, Colleen M [VerfasserIn]
Perera, Subashan [VerfasserIn]
Reynolds, Maureen D [VerfasserIn]
Handler, Steven M [VerfasserIn]
Kellum, John A [VerfasserIn]
Aspinall, Monica B [VerfasserIn]
Pellett, Megan E [VerfasserIn]
Long, Keith E [VerfasserIn]
Nace, David A [VerfasserIn]
Boyce, Richard D [VerfasserIn]

Links:

Volltext

Themen:

Adverse drug events
Clinical decision support
Journal Article
Medication errors
Nursing home
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Telemedicine

Anmerkungen:

Date Completed 17.09.2021

Date Revised 17.09.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/jgs.16946

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31799736X